Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03559751 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
A Phase 1 study of Tobacco Use, sponsored by 22nd Century Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT03559751 is a Phase 1 study of Tobacco Use that has completed, run by 22nd Century Group. The registered enrollment target is 66 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03559751, a Phase 1 study of Tobacco Use, has completed, sponsored by 22nd Century Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate the abuse liability of very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes
Conditions Studied
Interventions
- OTHER VLN cigarettes (A)
- OTHER Usual Brand Cigarettes (B)
- DRUG Nicotine gum (C)
Study Locations (1)
Kansas
- Vince & Associates Clinical Research, Inc - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-04-13 |
| Est. Completion | 2018-09-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03559751
The ClinicalTrials.gov registry entry for NCT03559751 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower). The listed sponsor is 22nd Century Group, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 3 interventions - of which VLN cigarettes (A) is the first listed.
NCT03559751 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03559751 about?
NCT03559751 is a clinical study titled "Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes". This study is designed to evaluate the abuse liability of very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes
What is the current status of trial NCT03559751?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2018-04-13. Estimated completion is 2018-09-06.
What conditions does trial NCT03559751 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT03559751?
The interventions under investigation include: VLN cigarettes (A) (OTHER), Usual Brand Cigarettes (B) (OTHER), Nicotine gum (C) (DRUG).
Who is sponsoring clinical trial NCT03559751?
This trial is sponsored by 22nd Century Group, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03559751 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Oral Cannabidiol for Tobacco Cessation
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Emergency Department Initiated Tobacco Treatment (EDITT)
COMPLETED · Phase 1
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.